News Focus
News Focus
Followers 16
Posts 1402
Boards Moderated 0
Alias Born 07/27/2015

Re: Mikesc post# 97060

Wednesday, 03/22/2017 3:53:07 PM

Wednesday, March 22, 2017 3:53:07 PM

Post# of 516880
Its actually from the latest pr.

I believe that Missling is preparing the company to defend against one though. Maybe there was an offer and he turned it down knowing Anavex is worth a lot more. So as a precaution, this is in play as well as the Shareholder rights plan.

Imagine this scenario:

Biogen tested our drug and found it to work better than their own MS drug. On top of that, Biogen knows that their Alzheimer candidate is inferior to our drug. So why would they license MS, leaving the other cash cow available for someone else?

Then theres Axon and their ceo and hedge fund crooks. They seem to have the resources to launch a take-over knowing how much spent now would return to them later in multiples.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News